Punjab Chemicals FY26 Revenue Grows 14.4% to ₹1,030 Cr; PAT Jumps 64.3% to ₹64 Cr
Punjab Chemicals reported FY26 revenue of ₹1,030 crore, up 14.4% YoY, and PAT of ₹64 crore, a 64.3% increase. Q4 FY26 revenue was ₹209 crore (+3.1% YoY) and PAT was ₹11 crore (+55.8% YoY). The company signed three MOUs for export products and plans ₹60 crore capex over six quarters.
Significant growth in key financial metrics (revenue, PAT, EBITDA) and strategic initiatives like new product launches, export-oriented MOUs, and capital expenditure plans indicate a substantial positive impact on the company's future prospects.
The company has demonstrated strong year-on-year growth in revenue and profit after tax for both the quarter and the full fiscal year, alongside margin improvements and strategic expansion plans.
Punjab Chemicals & Crop Protection Limited (PCCPL) announced its financial results for the fourth quarter and full fiscal year ended March 31, 2026. The company reported a consolidated revenue of ₹208.6 crore for Q4 FY26, marking a 3.1% year-on-year (YoY) increase. For the full fiscal year FY26, revenue reached ₹1,029.8 crore, a significant 14.4% YoY growth, driven by improved domestic and export sales and increased demand. New products contributed 14% to the FY26 revenue, growing by 16% YoY.
Gross margins for the quarter stood at 49.4%, up by 590 basis points YoY, while for the full year, margins were 40.1%, attributed to product mix and efficiency gains. EBITDA for Q4 FY26 was ₹27.5 crore with a margin of 13.2%. Full-year EBITDA grew by 19.1% to ₹118.1 crore, fueled by operational efficiencies and a refined product portfolio.
Profit After Tax (PAT) for the quarter saw a strong YoY growth of 55.8% to ₹11 crore, with PAT margins at 5.3%. For FY26, PAT jumped by 64.3% to ₹64.0 crore, and the corresponding margin improved to 6.2% from 4.3% in FY25.
The company highlighted strategic partnerships with three MOUs signed for export-oriented products, expected to commercialize in FY27. Domestically, a new agrochemical product (Herbicide) was commercialized in Q1. PCCPL also has additional products on track for commercialization over the next 2-3 quarters and is expanding its R&D facility at Derabassi, with a new project initiated at Lalru. Commercial production trials are underway for 4 new products.
PCCPL has planned capital investments of approximately ₹60 crore over the next 6 quarters for a new manufacturing block and capacity debottlenecking. The company is also actively scouting for a new site to support its growing operations and product range, with a focus on export growth.
What to do with a filing like this
Punjab Chemicals & Crop Protection Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Punjab Chemicals & Crop Protection Limited. Read the original for the full detail.